Biocure Technology Inc.
Biocure Technology Inc.
CSE Index:
Currency:
Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.
Biocure Technology Inc. (CURE)
SEDAR Information
Company Info
Address
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
CanadaPhone
604-609-7146Fax
N/AEmail
admin@biocuretech.comWebsite
http://www.biocuretech.comListing date
Monday, May 10, 2010Transfer Agent
Computershare Investor Services Inc.Investor Relations
Purple Crown Communications Corp.Email
Julie@purplecrown.caAuditor
DMCL Chartered Professional AccountantsCapitalization
Issued & Outstanding:
106,621,158Reserved for Issuance:
0News Releases
Bulletins
28/11/2017
2017-1117 – Fundamental Change – Gravis Energy Corp./Biocure Technology Inc.
le 28 novembre/November 2017
Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.
Listing and disclosure documents will be available at thecse.com on the trading date.
Advertisement
Publicité
